Nigeria’s fight against tuberculosis (TB) is facing a serious challenge as health workers and advocacy groups raise concerns about shortages of essential TB medicines and diagnostic supplies across the country.
Reports published on November 5 and 6, 2026, by The Sun and The Guardian say health facilities in several parts of the country have experienced shortages of essential TB commodities for almost two months. Health workers warn that available supplies may not be enough to meet patients’ needs through December.
The concerns were raised by health workers and civil society organisations during a journalists’ training on drug-resistant tuberculosis reporting organised by the Civil Society for the Eradication of Tuberculosis in Nigeria, also known as TB Network.
Shortage of essential TB medicines raises concern
According to the reports, some essential tuberculosis medicines are currently unavailable in health facilities across the country.
TB Network National Coordinator, Olayide Akanni, reportedly said three TB medications were experiencing nationwide stock-outs, while some states had gone almost two months without adequate supplies.
The shortage is also affecting newly diagnosed patients. Health workers say some facilities are struggling to provide immediate treatment because the medicines available are insufficient to meet demand.
There are also concerns about the shortage of Tuberculosis Preventive Treatment (TPT), which is given to eligible people who have been exposed to TB to reduce their risk of developing active tuberculosis.
People living with HIV and close contacts of infectious TB patients are among those who may need preventive treatment, depending on clinical assessment.
Delayed funding adds to the problem
The reports also point to concerns about delayed government funding for tuberculosis programmes.
TB advocates are calling on the Federal Government to release the funding required to procure essential TB medicines and diagnostic supplies.
The Guardian reported that the TB Network was demanding the release of about ₦72.5 billion, equivalent to $54 million, which it said had been earmarked for the procurement of TB medicines and diagnostics.
Although funding commitments have been announced, advocates say the delay in making the money available has affected the procurement of essential supplies.
The situation has raised questions about the sustainability of Nigeria’s tuberculosis response and the country’s reliance on external funding for some health programmes.
Why a shortage of TB medicines is dangerous
Tuberculosis is an infectious disease that mainly affects the lungs, although it can affect other parts of the body.
It spreads through the air when someone with infectious TB coughs, sneezes or speaks. Common symptoms include a persistent cough, chest pain, fever, night sweats, weight loss and fatigue.
TB can be treated with a combination of medicines taken over a prescribed period. However, treatment needs to be properly managed by qualified health professionals.
When patients cannot access their prescribed medicines or treatment is interrupted, they may remain ill for longer. This can increase the risk of further transmission and contribute to the development or spread of drug-resistant tuberculosis.
Drug-resistant TB is more difficult to treat and may require longer, more complex treatment.
What patients should do
People receiving tuberculosis treatment should not stop taking their medicines, change their doses or share their medication with anyone else without speaking to a qualified healthcare professional.
If a prescribed medicine is unavailable at a health facility, patients should contact their TB treatment provider or the relevant healthcare team for guidance on the next steps.
Anyone experiencing symptoms such as a persistent cough, fever, night sweats or unexplained weight loss should seek medical assessment rather than self-medicate.
Patients should also attend their scheduled follow-up appointments and inform their healthcare providers if they experience difficulties accessing their medicines.
Urgent action needed to protect TB patients
The reported shortage highlights the importance of a reliable supply of essential medicines and diagnostic materials in the fight against tuberculosis.
Health workers and advocacy groups are urging the Federal Government to address the shortages and ensure that funds for TB programmes are released so that patients can access the medicines and services they need.
Without timely intervention, treatment disruptions could make tuberculosis harder to control and place more patients and communities at risk.
For patients, families and healthcare workers, access to consistent TB treatment remains essential to protecting lives and preventing further spread of the disease.
